Nancy Lurker is Director of Alkermes plc.. Currently has a direct ownership of 4,616 shares of ALKS, which is worth approximately $124,632. The most recent transaction as insider was on Apr 11, 2025, when has been sold 1,459 shares (Ordinary Shares) at a price of $27.0 per share, resulting in proceeds of $39,393. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.62K
n/a 3M change
n/a 12M change
Total Value Held $124,632

Nancy Lurker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 11 2025
SELL
Payment of exercise price or tax liability
$39,393 $27.0 p/Share
1,459 Reduced 24.02%
4,616 Ordinary Shares
Apr 11 2025
BUY
Exercise of conversion of derivative security
-
6,075 Added 52.41%
5,517 Ordinary Shares

Also insider at

EYPT
EyePoint Pharmaceuticals, Inc. Healthcare
AQST
Aquestive Therapeutics, Inc. Healthcare
COLL
COLLEGIUM PHARMACEUTICAL, INC Healthcare
NL

Nancy Lurker

Director
Watertown, MA

Track Institutional and Insider Activities on ALKS

Follow Alkermes plc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALKS shares.

Notify only if

Insider Trading

Get notified when an Alkermes Plc. insider buys or sells ALKS shares.

Notify only if

News

Receive news related to Alkermes plc.

Track Activities on ALKS